5305 articles
Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen's Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma.
Catherine Bornbaum, PhD, MBA, Head of Clinical Operations and Partnerships at RetiSpec discusses using hyperspectral retinal imaging and artificial inte...
David Drapkin, LCSW, discusses Vital, a holistic, immersive, 12-month program launched by Psychedelics Today that is designed for medical professionals,...
Ran Anbar, MD, FAAP, leading expert in clinical hypnosis and Psychology Today contributor discusses clinical hypnosis, history, and misconceptions.
Ran Anbar, MD, FAAP, a leading expert in clinical hypnosis and Psychology Today contributor discusses clinical hypnosis and what kind of medical and emo...
President Biden recently announced a multi-faceted cancer pledge with the goal of reducing mortality from the disease by 50 percent during the next 25 y...
Emily Paul, a molecular biologist with a specialty in genetics and Product Director for SOHPiA GENETICS DDMTM discusses processing thousands of ge...
Terence Rooney, Vice President, Rheumatology & Maternal-Fetal Immunology Disease Area Leader at Janssen discusses Janssen's announcement of a comprehens...
Craig Parker, President and CEO of Surrozen, a biotechnology company discusses how the company is discovering and developing drug candidates to selectiv...
Jeff Bova, Chief Commercial Officer at UroGen Pharma discusses the launch of their first FDA-approved treatment, the only non-surgical option for patien...